Multidrug-Resistant Tuberculosis Complicated by Nosocomial Infection with Multidrug-Resistant Enterobacteriaceae

Standard

Multidrug-Resistant Tuberculosis Complicated by Nosocomial Infection with Multidrug-Resistant Enterobacteriaceae. / Gröschel, Matthias I; Omansen, Till F.; de Lange, Wiel; van der Werf, Tjip S; Lokate, Mariëtte; Bathoorn, Erik; Akkerman, Onno W; Stienstra, Ymkje.

in: AM J TROP MED HYG, Jahrgang 94, Nr. 3, 03.2016, S. 517-518.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungAndere (Vorworte u.ä.)Forschung

Harvard

Gröschel, MI, Omansen, TF, de Lange, W, van der Werf, TS, Lokate, M, Bathoorn, E, Akkerman, OW & Stienstra, Y 2016, 'Multidrug-Resistant Tuberculosis Complicated by Nosocomial Infection with Multidrug-Resistant Enterobacteriaceae', AM J TROP MED HYG, Jg. 94, Nr. 3, S. 517-518. https://doi.org/10.4269/ajtmh.15-0690

APA

Gröschel, M. I., Omansen, T. F., de Lange, W., van der Werf, T. S., Lokate, M., Bathoorn, E., Akkerman, O. W., & Stienstra, Y. (2016). Multidrug-Resistant Tuberculosis Complicated by Nosocomial Infection with Multidrug-Resistant Enterobacteriaceae. AM J TROP MED HYG, 94(3), 517-518. https://doi.org/10.4269/ajtmh.15-0690

Vancouver

Bibtex

@article{8a846b8e62354da5b8717374a079c1da,
title = "Multidrug-Resistant Tuberculosis Complicated by Nosocomial Infection with Multidrug-Resistant Enterobacteriaceae",
abstract = "Treatment of mycobacterial diseases such as tuberculosis (TB) entails long and intense antimicrobial therapy. TB patients are at risk of coinfection with other multidrug-resistant bacteria, such as those from Enterobacteriaceae family, because of antimicrobial selection pressure and nosocomial transmission during prolonged hospital admission. Here, we report on two patients treated for multidrug-resistant TB, who developed severe sepsis due to an extended spectrum β-lactamase producing organism. Diagnostic culture identified the venous access port as source, and upon surgical removal and antimicrobial therapy rapid clinical improvement was achieved. Increased awareness and knowledge on the prevalence of multi-resistant Enterobacteriaceae is needed, notably in TB centers, to provide a safe hospital environment to our patients. ",
keywords = "Adult, Anti-Bacterial Agents/pharmacology, Antitubercular Agents/administration & dosage, Cross Infection, Enterobacteriaceae, Enterobacteriaceae Infections/etiology, Female, Humans, Tuberculosis, Multidrug-Resistant/complications",
author = "Gr{\"o}schel, {Matthias I} and Omansen, {Till F.} and {de Lange}, Wiel and {van der Werf}, {Tjip S} and Mari{\"e}tte Lokate and Erik Bathoorn and Akkerman, {Onno W} and Ymkje Stienstra",
note = "{\textcopyright} The American Society of Tropical Medicine and Hygiene.",
year = "2016",
month = mar,
doi = "10.4269/ajtmh.15-0690",
language = "English",
volume = "94",
pages = "517--518",
journal = "AM J TROP MED HYG",
issn = "0002-9637",
publisher = "American Society of Tropical Medicine and Hygiene",
number = "3",

}

RIS

TY - JOUR

T1 - Multidrug-Resistant Tuberculosis Complicated by Nosocomial Infection with Multidrug-Resistant Enterobacteriaceae

AU - Gröschel, Matthias I

AU - Omansen, Till F.

AU - de Lange, Wiel

AU - van der Werf, Tjip S

AU - Lokate, Mariëtte

AU - Bathoorn, Erik

AU - Akkerman, Onno W

AU - Stienstra, Ymkje

N1 - © The American Society of Tropical Medicine and Hygiene.

PY - 2016/3

Y1 - 2016/3

N2 - Treatment of mycobacterial diseases such as tuberculosis (TB) entails long and intense antimicrobial therapy. TB patients are at risk of coinfection with other multidrug-resistant bacteria, such as those from Enterobacteriaceae family, because of antimicrobial selection pressure and nosocomial transmission during prolonged hospital admission. Here, we report on two patients treated for multidrug-resistant TB, who developed severe sepsis due to an extended spectrum β-lactamase producing organism. Diagnostic culture identified the venous access port as source, and upon surgical removal and antimicrobial therapy rapid clinical improvement was achieved. Increased awareness and knowledge on the prevalence of multi-resistant Enterobacteriaceae is needed, notably in TB centers, to provide a safe hospital environment to our patients.

AB - Treatment of mycobacterial diseases such as tuberculosis (TB) entails long and intense antimicrobial therapy. TB patients are at risk of coinfection with other multidrug-resistant bacteria, such as those from Enterobacteriaceae family, because of antimicrobial selection pressure and nosocomial transmission during prolonged hospital admission. Here, we report on two patients treated for multidrug-resistant TB, who developed severe sepsis due to an extended spectrum β-lactamase producing organism. Diagnostic culture identified the venous access port as source, and upon surgical removal and antimicrobial therapy rapid clinical improvement was achieved. Increased awareness and knowledge on the prevalence of multi-resistant Enterobacteriaceae is needed, notably in TB centers, to provide a safe hospital environment to our patients.

KW - Adult

KW - Anti-Bacterial Agents/pharmacology

KW - Antitubercular Agents/administration & dosage

KW - Cross Infection

KW - Enterobacteriaceae

KW - Enterobacteriaceae Infections/etiology

KW - Female

KW - Humans

KW - Tuberculosis, Multidrug-Resistant/complications

U2 - 10.4269/ajtmh.15-0690

DO - 10.4269/ajtmh.15-0690

M3 - Other (editorial matter etc.)

C2 - 26755567

VL - 94

SP - 517

EP - 518

JO - AM J TROP MED HYG

JF - AM J TROP MED HYG

SN - 0002-9637

IS - 3

ER -